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the expression of p53 (p < 0.0001) and the presence of lichen sclerosus (p
= 0.0051). It is curious that 4 keratinizing carcinomas of the cases studied
presented coexpression of p16 and p53. Only 1 warty tumour was nega-
tive for p16 and positive for p53, and 9 keratinizing tumourswere positive
for p16 and negative for p53. Four of them were PCR positive for high
risk HPV.
Conclusion: Although these findings show that the use of hematoxylin
and eosin could correctly define tumours associated with HPV, we
strongly suggest the performance of immunohistochemistry, especially
in squamous keratinizing classic carcinomas in young patients with a
history of HPV.
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Background & objectives: Objective: Our study aimed to analyse the
immunoexpression of p53 and c-FLIP in ovarian carcinoma in relation-
ship with the clinicopathological features.
Methods: The study group consisted of 63 cases of ovarian carcinomas
histopathologically diagnosed as serous (44 cases), and non-serous (19
cases); 24 cases were classified as stage I-II and 39 as stage III; 12 cases
were assessed as G1, 24 cases as G2, 27 cases as G3 and G4. Tissue
fragments were immunohistochemically processed by using anti-p53 and
c-FLIP antibodies.
Results: c-FLIP+/p53+ expression was noted in 15 cases and negative in
14 cases. 17 cases exhibited c-FLIP-/p53+ and c-FLIP+/p53- respectively.
Cases with c-FLIP+/p53- profile had the following distribution according
to tumour stage: 8 in stage I and 9 in stage III, and tumour grade: G1 in 6
cases, G2 in 8 cases and G3 in 3 cases. Cases presenting c-FLIP-/p53+
profile were framed as follows: 2 in stage I, 2 in stage II and 13 in stage III;
1 case was graded as G1, 6 cases as G2, 9 cases as G3 and 1 case as G4.
Statistical analysis revealed significant differences between c-FLIP+/p53-
and, respectively, c-FLIP-/p53+ expression, and tumour grade.
Conclusion: The study of FLIP and p53 molecules provides integrated
images of the apoptotic mechanism based on a cross-talk between the
intrinsic and extrinsic pathways
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Background & objectives: Endometrial cells acquire new peculiarities
during malignant transformation and progression, which plays a signifi-
cant role in the behaviour of neoplastic cells.
The objective of our study presented here was to characterize hsp70 and
hsp90 expressions in normal and tumour endometrium.
Methods: The investigation was conducted on 50 samples with different
types (endometrioid, serous and clear-cell) endometrial carcinoma. Ten
cases of normal endometrium were used for comparison. The presence of
hsp70 and hsp90 was detected by the immunohistochemistry utilizing the
mouse mAb W27 and rabbit pAb (0.1μg/ml), respectively.
Results: Normal endometrium is characterized by the focal nuclear-
cytoplasmic expression of hsp70. Endometrial carcinomas showed an
increase in its expression in tumour cells with the appearance of hsp90.
The de-differentiation of tumours was accompanied by increase chaper-
one response. Both were found in a high proportion of cancer cells. It
should be noted, that most neoplasias had a heterogeneous expression of
chaperons in tumour tissue.
Conclusion: The occurrence and progression of endometrial carcinomas
are accompanied by the change hsp70 and hsp90 expression in tumour
cells. They acquire additional resistance due to the synthesis of chaper-
ones which increase their survival.
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Background & objectives: Chronic abruption-oligohydramnios se-
quence (CAOS) is characterized by diffuse chorioamniotic hemosiderosis
(DCH). We compared the degree and distribution pattern of hemosiderin
deposition (HD) on the chorionic plate (CP) and free membrane (FM).
Methods: We selected 20 CAOS patients, 21 non-CAOS patients as
control group A (CA) matched by gestational weeks and 21 non-CAOS
patients as control group B (CB) with bloody amniotic fluid. Iron staining
of CP and FM was performed for every case. HD was evaluated by a
histological score (HS) determined as positivity (0-3) multiplied by the
staining area extent (0-4).
Results: HD was found in 100% (20/20) of CAOS patients and 14%
(3/21) of CA and 9.5% (2/21) of CB patients. In both FM and CP,
CAOS patients showed a significantly higher HS than control patients
(CAOS, HS=4-12; CA, HS=0-1, p<0.0001; CB, HS=0-3, p<0.0001). In
three CAOS patients, HDwas seen only in the CP. The HS of the CP was
significantly higher than that of the FM (p=0.0003).
Conclusion:CAOSwas histologically characterized byDCHwith an HS
≥4. The CP was better suited for the evaluation of DCH than the FM.
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Background& objectives: In Scotland, suspectedmolar pregnancies are
referred by the local pathologist to the Scottish Hydatidiformmole service
(SHMS) in Dundee. This is a review of those cases that were diagnosti-
cally challenging and were submitted for molecular genotyping.
Methods: Submitted slides and blocks are booked in and ploidy
analysis undertaken on all cases. If diploid, P57 immunohisto-
chemistry (IHC) performed. Slides are reviewed by the pathologist
and a final diagnosis of complete or partial mole or non-molar
pregnancy reported. Molecular studies were undertaken if the di-
agnosis was equivocal. Genotyping was performed on DNA ex-
tracted from chorionic villi and maternal decidua.
Results: 689 cases received between 2017 and 2019. Histology, ploidy
analysis and p57 IHC sufficient for diagnosis of 95% of referrals. The
remaining 5% (34/689) were submitted for molecular genotyping to con-
firm the diagnosis. Where required, specific populations of chorionic villi
or regions of discordant P57 expression were microdissected. Results
showed, 56% (19/34) of cases were associated with a molar genotype
including complete heterozygous or homozygous complement, or
diandric triploidy. This included 5 cases of complex results including
mosaicism and triandric tetraploidy. Biparental inheritance was reported
in 15% (5/34) of cases. 18% (6/34) of cases were uninterpretable and the
remaining 12% (4/34) of caseswere associated with trisomy 21 or digynic
triploidy.
Conclusion: Only a small number of cases submitted to the SHMS re-
quired further investigation by molecular genotyping with several cases
showing complex results that could not be reliably established by other
methods. This work reviews the range of diverse and complex cases seen
by a national referral centre.
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